Pelletier-Galarneau 2021 Curr Cardiol Rep: Difference between revisions

From Bioblast
No edit summary
No edit summary
Β 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{Publication
{{Publication
|title=Pelletier-Galarneau M, Detmer FJ, Petibon Y, Normandin M, Ma C, Alpert NM, El Fakhri G (2021) Quantification of myocardial mitochondrial membrane potential using PET. Curr Cardiol Rep 23:70. doi: 10.1007/s11886-021-01500-8
|title=Pelletier-Galarneau M, Detmer FJ, Petibon Y, Normandin M, Ma C, Alpert NM, El Fakhri G (2021) Quantification of myocardial mitochondrial membrane potential using PET. Curr Cardiol Rep 23:70. https://doi.org/10.1007/s11886-021-01500-8
|info=[https://pubmed.ncbi.nlm.nih.gov/33970353/ PMID: 33970353 Open Access]
|info=[https://pubmed.ncbi.nlm.nih.gov/33970353/ PMID: 33970353 Open Access]
|authors=Pelletier-Galarneau M, Detmer FJ, Petibon Y, Normandin M, Ma C, Alpert NM, El Fakhri G
|authors=Pelletier-Galarneau M, Detmer FJ, Petibon Y, Normandin M, Ma C, Alpert NM, El Fakhri G
Line 10: Line 10:
|editor=Gnaiger E
|editor=Gnaiger E
}}
}}
[[File:Pelletier-Galarneau 2021 Curr Cardiol Rep CORRECTION.png|right|400px]]
[[File:Pelletier-Galarneau 2021 Curr Cardiol Rep CORRECTION.png|right|300px]]
{{Template:Correction FADH2 and S-pathway}}
{{Template:Correction FADH2 and S-pathway}}
{{Labeling
{{Labeling
|enzymes=Complex II;succinate dehydrogenase
|enzymes=Complex II;succinate dehydrogenase
}}
}}

Latest revision as of 12:15, 15 October 2023

Publications in the MiPMap
Pelletier-Galarneau M, Detmer FJ, Petibon Y, Normandin M, Ma C, Alpert NM, El Fakhri G (2021) Quantification of myocardial mitochondrial membrane potential using PET. Curr Cardiol Rep 23:70. https://doi.org/10.1007/s11886-021-01500-8

Β» PMID: 33970353 Open Access

Pelletier-Galarneau M, Detmer FJ, Petibon Y, Normandin M, Ma C, Alpert NM, El Fakhri G (2021) Curr Cardiol Rep

Abstract: Purpose of review: To present a method enabling in vivo quantification of tissue membrane potential (ΔΨT), a proxy of mitochondrial membrane potential (ΔΨm), to review the origin and role of ΔΨm, and to highlight potential applications of myocardial ΔΨT imaging.

Recent findings: Radiolabelled lipophilic cations have been used for decades to measure ΔΨm in vitro. Using similar compounds labeled with positron emitters and appropriate compartment modeling, this technique now allows in vivo quantification of ΔΨT with positron emission tomography. Studies have confirmed the feasibility of measuring myocardial ΔΨT in both animals and humans. In addition, ΔΨT showed very low variability among healthy subjects, suggesting that this method could allow detection of relatively small pathological changes. In vivo assessment of myocardial ΔΨT provides a new tool to study the pathophysiology of cardiovascular diseases and has the potential to serve as a new biomarker to assess disease stage, prognosis, and response to therapy.

β€’ Bioblast editor: Gnaiger E

Pelletier-Galarneau 2021 Curr Cardiol Rep CORRECTION.png

Correction: FADH2 and Complex II

Ambiguity alert.png
FADH2 is shown as the substrate feeding electrons into Complex II (CII). This is wrong and requires correction - for details see Gnaiger (2024).
Gnaiger E (2024) Complex II ambiguities ― FADH2 in the electron transfer system. J Biol Chem 300:105470. https://doi.org/10.1016/j.jbc.2023.105470 - Β»Bioblast linkΒ«

Labels:



Enzyme: Complex II;succinate dehydrogenase 




Cookies help us deliver our services. By using our services, you agree to our use of cookies.